These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 8905327
41. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR. J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305 [Abstract] [Full Text] [Related]
42. Pharmacological evaluation of aerosolized cannabinoids in mice. Lichtman AH, Peart J, Poklis JL, Bridgen DT, Razdan RK, Wilson DM, Poklis A, Meng Y, Byron PR, Martin BR. Eur J Pharmacol; 2000 Jul 07; 399(2-3):141-9. PubMed ID: 10884513 [Abstract] [Full Text] [Related]
43. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Arévalo C, de Miguel R, Hernández-Tristán R. Pharmacol Biochem Behav; 2001 Sep 07; 70(1):123-31. PubMed ID: 11566149 [Abstract] [Full Text] [Related]
44. Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. Aceto MD, Scates SM, Razdan RK, Martin BR. J Pharmacol Exp Ther; 1998 Nov 07; 287(2):598-605. PubMed ID: 9808686 [Abstract] [Full Text] [Related]
45. Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Souilhac J, Poncelet M, Rinaldi-Carmona M, Le Fur G, Soubrié P. Pharmacol Biochem Behav; 1995 May 07; 51(1):3-7. PubMed ID: 7617730 [Abstract] [Full Text] [Related]
47. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. Darmani NA, Pandya DK. J Neural Transm (Vienna); 2000 May 07; 107(8-9):931-45. PubMed ID: 11041273 [Abstract] [Full Text] [Related]
53. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Parker LA, Mechoulam R, Schlievert C, Abbott L, Fudge ML, Burton P. Psychopharmacology (Berl); 2003 Mar 07; 166(2):156-62. PubMed ID: 12528012 [Abstract] [Full Text] [Related]
58. Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway. Caillé S, Parsons LH. Neuropsychopharmacology; 2006 Apr 23; 31(4):804-13. PubMed ID: 16123766 [Abstract] [Full Text] [Related]
59. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A. Järbe TU, Lamb RJ, Liu Q, Makriyannis A. Eur J Pharmacol; 2003 Apr 11; 466(1-2):121-7. PubMed ID: 12679148 [Abstract] [Full Text] [Related]